Palma, Baby Boy .
HRN: 24-06-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/15/2023
12/22/2023
IV
38mg
Q24
Neonatal Asphyxia
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes